499 filings
Page 4 of 25
8-K/A
jwbqkkh35
30 Jul 21
Financial Statements and Exhibits
11:09am
8-K
68xhl
28 Jul 21
Cytocom Inc. Announces Completed Merger with Cleveland BioLabs
8:30am
8-K
hcxavfp22
6 Jul 21
Departure of Directors or Certain Officers
5:01pm
425
og2t xx9stngi
17 Jun 21
Business combination disclosure
5:16pm
EFFECT
ihwtq3fj0f00v3mfbl
11 Jun 21
Notice of effectiveness
12:15am
424B3
o3bxzuxbjxdz 8k6mi
10 Jun 21
Prospectus supplement
5:02pm
CORRESP
c6i4uq
8 Jun 21
Correspondence with SEC
12:00am
CORRESP
pvf0rymh3t
4 Jun 21
Correspondence with SEC
12:00am
UPLOAD
b57wy7bzxwed3 je9
24 May 21
Letter from SEC
12:00am
S-4/A
mkm358dw0ivklcfwo
7 May 21
Registration of securities issued in business combination transactions (amended)
5:10pm
CORRESP
rzbe9pgyjryx9njw
7 May 21
Correspondence with SEC
12:00am
UPLOAD
pi0xzxqt wc
25 Feb 21
Letter from SEC
12:00am
8-K
t1wl5fip5o5l2 pm
23 Feb 21
Cleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common Stock
5:30pm
424B5
55jiq
22 Feb 21
Prospectus supplement for primary offering
5:21pm
8-K
6o8wez2yfq8hkjkcdx
19 Feb 21
Results of Operations and Financial Condition
8:52am
8-K
iks722bsqzkblyl aclq
17 Feb 21
Other Events
4:18pm
425
q5dg3aszj7sk0
17 Feb 21
Business combination disclosure
4:16pm